Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design

Lisa Daniel-Fischer, Marlies Antlanger, Daniel Cejka, Kathrin Eller, Philipp Gauckler, Balazs Odler, Michael Rudnicki, Marcus D Säemann, Alice Schmidt, Gere Sunder-Plassmann, Martin Wiesholzer, Martin Windpessl, Emanuel Zitt, Franz Koenig, Larry A Greenbaum, Andreas Kronbichler, Christoph Aufricht*

*Corresponding author for this work

Research output: Journal article (peer-reviewed)Letter/short communication

Original languageEnglish
Pages (from-to)478-481
Number of pages4
JournalKidney International Reports
Volume9
Issue number2
DOIs
Publication statusPublished - 02 Feb 2024

Keywords

  • FSGS
  • clopidogrel
  • drug repurposing
  • proteinuria

ASJC Scopus subject areas

  • Nephrology

Cite this